Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs.
Freba GraweNatalie RosenbergerMaria IngenerfLeonie BeyerRalf EschbachAndrei TodicaRicarda SeidenstickerChristine Schmid-TannwaldClemens C CyranJens RickePeter BartensteinChristoph J AuernhammerJohannes RuebenthalerMatthias Philipp FabritiusPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)
This study confirms the high diagnostic accuracy of SSR-PET/CT in the detection of hepatic involvement in NET patients based on a patient-based analysis of metastatic hepatic involvement with a high sensitivity and specificity using liver MRI imaging as reference standard. However, one should be aware of possible pitfalls when a single imaging method is used in evaluating neuroendocrine liver metastases in patients.
Keyphrases
- pet ct
- liver metastases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- high resolution
- small cell lung cancer
- magnetic resonance imaging
- peritoneal dialysis
- positron emission tomography
- prognostic factors
- mass spectrometry
- computed tomography
- squamous cell carcinoma
- quantum dots
- contrast enhanced
- loop mediated isothermal amplification